Healthcare -
Medical - Instruments & Supplies - NASDAQ - US
$ 5.2
-4.41 %
$ 5.3 M
Market Cap
None
P/E
1. INTRINSIC VALUE
2. FUNDAMENTAL
ANALYSIS
Price Chart STSS
FINANCIALS
Balance Sheet
Sharps Technology, Inc.
| Current Assets | 3.17 M |
| Cash & Short-Term Investments | 864 K |
| Receivables | 102 K |
| Other Current Assets | 2.21 M |
| Non-Current Assets | 4.14 M |
| Long-Term Investments | 0 |
| PP&E | 4.04 M |
| Other Non-Current Assets | 105 K |
| Current Liabilities | 5.19 M |
| Accounts Payable | 977 K |
| Short-Term Debt | 3.76 M |
| Other Current Liabilities | 445 K |
| Non-Current Liabilities | 132 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 132 K |
EFFICIENCY
Earnings Waterfall
Sharps Technology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 774 K |
| Gross Profit | 0 |
| Operating Expenses | 9.63 M |
| Operating Income | -9.63 M |
| Other Expenses | -331 K |
| Net Income | -9.3 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sharps Technology, Inc.
| Net Income | -9.3 M |
| Depreciation & Amortization | 774 K |
| Capital Expenditures | -139 K |
| Stock-Based Compensation | 521 K |
| Change in Working Capital | -426 K |
| Others | 1.53 M |
| Free Cash Flow | -7.07 M |
Wall Street Analysts Price Targets
Sharps Technology, Inc.
STSS has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
STSS does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Sharps Technology, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
10.8 K USD 1
3-6 MONTHS
20.1 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Sharps Technology Shares Climb on Latest SoloGard Shipments
Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.
marketwatch.com
- 2 weeks ago
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades
Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partner Strategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated the second shipment of its first commercial order of SoloGard syringes under a multi-year supply agreement with a U.S.-based leader in IV flushing solutions.
globenewswire.com
- 2 weeks ago
Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on June 12th, 2025 at 9:30 AM ET. Sharps recently announced that the Company has commenced shipments under three customer orders tied to previously announced purchase agreements.
globenewswire.com
- 3 weeks ago
Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
globenewswire.com
- 3 weeks ago
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here.
globenewswire.com
- 3 weeks ago
Why Is Sharps Technology Stock Soaring On Wednesday?
Sharps Technology, Inc. STSS stock is trading higher on Wednesday.
benzinga.com
- 4 weeks ago
Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements
Shipments include initial deliveries of SecureGard™ and SoloGard™ smart safety syringes from its Hungary-based manufacturing facility Deliveries mark the Company's transition to a commercial-stage, revenue-generating company NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced the initiation of shipments for previously announced purchase orders across three customer orders. These shipments mark the Company's first deliveries of its SecureGard™ and SoloGard™ product lines and its transition to generating commercial revenue.
globenewswire.com
- 4 weeks ago
Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq's Capital Market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.
globenewswire.com
- 1 month ago
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET. Presentation Details: Presenter: Robert Hayes, CEO Date: May 22, 2025 Time: 1:00 p.m.
globenewswire.com
- 1 month ago
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time.
globenewswire.com
- 3 months ago
Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary
Company is strategically positioned following the recent $20 million capital raise, enhancing manufacturing capabilities to accelerate qualification and shipments under existing agreements Company is strategically positioned following the recent $20 million capital raise, enhancing manufacturing capabilities to accelerate qualification and shipments under existing agreements
globenewswire.com
- 3 months ago
Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering
NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on January 29, 2025.
globenewswire.com
- 5 months ago
8. Profile
Summary
Sharps Technology, Inc. STSS
COUNTRY
US
INDUSTRY
Medical - Instruments & Supplies
MARKET CAP
$ 5.3 M
Dividend Yield
0.00%
Description
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Contact
105 Maxess Road, Melville, NY, 11747
https://sharpstechnology.com
IPO
Date
April 14, 2022
Employees
55
Officers
Mr. Robert M. Hayes
Chief Executive Officer & Director
Mr. Frank Parrado
Corporate Controller
Mr. Andrew R. Crescenzo CPA
Chief Financial Officer